GSK Investigational Site

Sayre, Pennsylvania 18840

0 studies enrolling now · 6 studies all time

What they study most

Acute Coronary Syndrome, Atherosclerosis, Lung Cancer, Non-Small Cell, Melanoma, Nausea, Nausea and Vomiting, Chemotherapy-Induced, Vomiting

Studies at this site

• A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor — Stopped early
• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial — Completed
• The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial — Completed
• Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer — Stopped early
• Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting — Completed